Utama › Limfoma Sel B Besar Difus › North Carolina › Durham
Kajian klinikal Limfoma Sel B Besar Difus di Durham, NC
14 kajian untuk Limfoma Sel B Besar Difus sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Mengambil pesertaFasa 2
- Duke Blood Cancer Center, Durham
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Mengambil pesertaFasa 3
- Duke University Medical Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Mengambil pesertaFasa 2
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · 10 mi jauh
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Mengambil pesertaFasa 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi jauh
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Mengambil pesertaKajian pemerhatian
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Mengambil pesertaFasa 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
Mengambil pesertaFasa 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauh
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Mengambil pesertaFasa 1
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Mengambil pesertaKajian pemerhatian
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauh
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Mengambil pesertaFasa 1
- University of North Carolina, Chapel Hill · 10 mi jauh
A Study of NX-1607 in Adults With Advanced Malignancies
Mengambil pesertaFasa 1
- University of North Carolina, Chapel Hill · 10 mi jauh
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Mengambil pesertaFasa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
Kajian Limfoma Sel B Besar Difus di bandar lain
- New York City, NY21 kajian
- Baldwin Park, CA19 kajian
- Chicago, IL18 kajian
- Houston, TX17 kajian
- Los Angeles, CA17 kajian
- Boston, MA16 kajian
- Milwaukee, WI16 kajian
- Nashville, TN15 kajian
- Portland, OR15 kajian
- Philadelphia, PA15 kajian
- Dallas, TX13 kajian
- Seattle, WA12 kajian
Kajian lain di Durham
- Kanser Payudara63 kajian
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil39 kajian
- Mieloma Pelbagai37 kajian
- Kanser Metastatik33 kajian
- Leukemia Mieloid Akut33 kajian
- Kanser Paru-paru32 kajian
- Kanser Prostat32 kajian
- Kanser Kolorektal28 kajian
- Leukemia Limfositik Kronik27 kajian
- Kanser Ovari27 kajian
- Kegagalan Jantung26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.